Cantor Fitzgerald Reiterates Overweight on Aziyo Biologics, Maintains $8 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Brandon Folkes has reiterated an Overweight rating on Aziyo Biologics (NASDAQ:AZYO) and maintained a price target of $8.
September 07, 2023 | 1:23 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald has reiterated an Overweight rating on Aziyo Biologics and maintained a price target of $8.
The reiteration of an Overweight rating by Cantor Fitzgerald indicates a positive outlook for Aziyo Biologics. The maintained price target of $8 suggests that the analyst believes the stock is undervalued at current levels, which could lead to upward price movement in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100